UPCOMING DEADLINE: Picard Medical, Inc. (PMI) Securities Fraud Class Action – April 13, 2026 Lead Plaintiff Deadline

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Picard Medical, Inc. due to allegations of securities law violations, encouraging affected investors to participate in a class action lawsuit [4][6]. Group 1: Legal Investigation and Class Action - The law firm is reminding investors of the April 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action against Picard Medical [4]. - Allegations against Picard Medical include involvement in a fraudulent stock promotion scheme, insider trading, and misleading public statements regarding the company's financial health [6]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding Picard Medical's conduct [9]. Group 2: Stock Performance and Impact - On October 24, 2025, Picard Medical's shares experienced a significant decline, closing at $5.31, down from $13.20 the previous day, marking a drop of $7.89 per share or approximately 59.8% [7].